# MicroRNAs in schizophrenia

> **NIH NIH R01** · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · 2021 · $421,237

## Abstract

PROJECT SUMMARY
This revised R01 application is submitted in response to PAR-14-309 and seeks to understand the
mechanisms by which a microRNA enriched in cortical parvalbumin-expressing (PV) GABAergic interneurons
regulates the activity of these cells and behaviors under their control. In prefrontal cortex (PFC), microRNA-206
(miR-206) is highly enriched in PV interneurons and its expression levels in post-mortem PFC correlate with
psychosis in schizophrenia and bipolar patients. In exciting preliminary data, we show that newly generated
miR-206 knockout mice demonstrate cellular and cognitive deficits consistent with the hypothesis that this
microRNA regulates PV interneuron function in PFC. The goals of this proposal are threefold: First, cellular and
behavioral abnormalities in miR-206 KO mice, and in KO mice in which miR-206 expression has been
“rescued” in cortical PV interneurons, will be assessed. To accomplish this Aim we have generated miR-206
knockout mice that express Cre recombinase in PV neurons. We will use a Cre-dependent expression vector
to re-express the otherwise deleted miRNA in cortical PV interneurons. We will then assess the strength of
synaptic connectivity between cortical PV interneurons and neighboring pyramidal neurons in PFC of miR-206
KO mice, KO mice with rescued miR-206 expression in cortical PV interneurons, and appropriate control
groups. We will also characterize aspects of cognition and emotionality controlled by cortical PV interneurons
in these mice. Second, the intracellular mechanisms by which miR-206 controls activity of PV interneurons,
and hence mPFC function, will be investigated. We will use High-Throughput Sequencing of RNA isolated by
CrossLinking ImmunoPrecipitation (HITS-CLIP) to identify genes targeted by miR-206 in cortical PV
interneurons. We will verify that identified genes are direct targets for miR-206 using 3'UTR luciferase reporter
assays, RNA expression analysis and protein immunoblotting. Third, the molecular mechanisms by which miR-
206 controls activity of PV interneurons, and hence mPFC function, will be investigated. Specifically, we will
use in vivo CRISPR technology to delete the most promising genes targeted by miR-206 in PV interneurons
and assess the behavioral consequences. The cutting-edge experiments proposed in this application will
facilitate greater understanding of the molecular mechanisms by which cortical PV interneuron activity is
regulated and may yield new insights into the pathophysiology of PV interneuron-related psychiatric disorders.

## Key facts

- **NIH application ID:** 10166931
- **Project number:** 5R01MH112168-05
- **Recipient organization:** ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
- **Principal Investigator:** Paul J. Kenny
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $421,237
- **Award type:** 5
- **Project period:** 2017-07-21 → 2022-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10166931

## Citation

> US National Institutes of Health, RePORTER application 10166931, MicroRNAs in schizophrenia (5R01MH112168-05). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10166931. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
